PL2146944T3 - Sposób otrzymywania folianów znakowanych fluorem-18 - Google Patents

Sposób otrzymywania folianów znakowanych fluorem-18

Info

Publication number
PL2146944T3
PL2146944T3 PL08736117T PL08736117T PL2146944T3 PL 2146944 T3 PL2146944 T3 PL 2146944T3 PL 08736117 T PL08736117 T PL 08736117T PL 08736117 T PL08736117 T PL 08736117T PL 2146944 T3 PL2146944 T3 PL 2146944T3
Authority
PL
Poland
Prior art keywords
preparation
folates
labelled
labelled folates
Prior art date
Application number
PL08736117T
Other languages
English (en)
Inventor
Simon Mensah Ametamey
Rudolf Moser
Tobias Ludwig Ross
Phoebe Lam
Viola Groehn
Original Assignee
Merck & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Cie filed Critical Merck & Cie
Publication of PL2146944T3 publication Critical patent/PL2146944T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL08736117T 2007-04-11 2008-04-11 Sposób otrzymywania folianów znakowanych fluorem-18 PL2146944T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07105976 2007-04-11
EP08736117.6A EP2146944B1 (en) 2007-04-11 2008-04-11 A method for the preparation of 18f-labelled folates
PCT/EP2008/054404 WO2008125613A1 (en) 2007-04-11 2008-04-11 18f-labelled folates

Publications (1)

Publication Number Publication Date
PL2146944T3 true PL2146944T3 (pl) 2014-05-30

Family

ID=39620260

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08736117T PL2146944T3 (pl) 2007-04-11 2008-04-11 Sposób otrzymywania folianów znakowanych fluorem-18

Country Status (15)

Country Link
US (2) US20100111864A1 (pl)
EP (1) EP2146944B1 (pl)
JP (1) JP2010523624A (pl)
KR (2) KR20160074683A (pl)
CN (2) CN107573347A (pl)
AU (1) AU2008237930B2 (pl)
CA (1) CA2670363C (pl)
DK (1) DK2146944T3 (pl)
EA (1) EA200901347A1 (pl)
ES (1) ES2449774T3 (pl)
IL (1) IL201248A (pl)
PL (1) PL2146944T3 (pl)
PT (1) PT2146944E (pl)
WO (1) WO2008125613A1 (pl)
ZA (1) ZA200903486B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2346870B1 (en) 2008-10-10 2015-08-05 Merck & Cie 18f-labelled folates as pet radiotracers
WO2012157900A2 (ko) * 2011-05-13 2012-11-22 서강대학교산학협력단 18f-표지 pet 방사성의약품의 전구체 및 그 제조방법
PL2776382T3 (pl) * 2011-08-22 2019-05-31 Merck & Cie 18f-sacharydo-foliany
KR102116000B1 (ko) 2012-05-08 2020-05-29 메르크 앤드 씨에 18f-표지된 폴레이트/안티폴레이트 유사체들
US10003388B2 (en) 2012-09-04 2018-06-19 Ntt Docomo, Inc. Method and apparatus for internal relative transceiver calibration
WO2016044645A1 (en) * 2014-09-17 2016-03-24 Elmaleh David R Anticoagulant derivatives for cardiovascular imaging
US11025322B2 (en) 2016-08-12 2021-06-01 Telefonaktiebolaget Lm Ericsson (Publ) Progressive advanced CSI feedback
MX2019001567A (es) 2016-08-12 2019-06-10 Ericsson Telefon Ab L M Mecanismos de notificacion ricos en informacion de estado de canal de capa 1 y capa 2.
CN115499922A (zh) 2016-08-12 2022-12-20 瑞典爱立信有限公司 用于高级csi反馈开销减少的可配置码本
KR102247005B1 (ko) 2016-08-12 2021-04-30 텔레호낙티에볼라게트 엘엠 에릭슨(피유비엘) 더 최적화된 오버헤드를 갖는 멀티-빔 코드북들
KR102031652B1 (ko) * 2018-01-19 2019-10-14 서울대학교산학협력단 전이체 단백질 과발현 관련 질환의 양성자방출단층촬영 방사성추적자, 형광영상 진단 및 광역학 치료를 위한 전이체 단백질 표적 리간드 및 이의 제조방법

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1458978A (en) * 1973-12-11 1976-12-22 Radiochemical Centre Ltd Saturation analysis
US4202976A (en) * 1973-09-11 1980-05-13 Bayly Russell J Selenium-75 labelled derivatives of folates
US3989812A (en) * 1974-08-09 1976-11-02 Smithkline Instruments, Inc. Folic acid derivatives and use in radio-assay
GB1501119A (en) 1974-12-20 1978-02-15 Radiochemical Centre Ltd Folate compounds
US4276280A (en) * 1976-09-29 1981-06-30 Becton, Dickinson And Company Radiolabeled derivatives of folic acid
US4298735A (en) * 1979-04-30 1981-11-03 Union Carbide Corporation Folic acid derivatives
US4337339A (en) * 1979-04-30 1982-06-29 Baker Instruments Corp. Process for preparation of folic acid derivatives
US4314988A (en) * 1979-10-31 1982-02-09 Baker Instruments Corp. Folic acid derivatives and process for preparation
JPS6144890A (ja) 1984-08-08 1986-03-04 Shionogi & Co Ltd 含フツ素メトトレキサ−ト誘導体
US4584375A (en) * 1984-08-21 1986-04-22 Rensselaer Polytechnic Institute Fluorine-containing antifolates incapable of polyglutamate formation
US4628090A (en) * 1984-08-21 1986-12-09 Rensselaer Polytechnic Institute Fluorine-containing antifolates incapable of polyglutanayte formation related compounds
US5286726A (en) 1990-04-12 1994-02-15 The Regents Of The University Of Michigan Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
US5066828A (en) * 1990-04-12 1991-11-19 Merrell Dow Pharmaceuticals Inc. Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
CA2156657C (en) 1994-11-02 1999-06-15 Richard G. Beauclerc Gravity wedge for a slackless railcar connector assembly
WO1999020626A1 (en) 1997-10-17 1999-04-29 Purdue Research Foundation Folic acid derivatives
US6093382A (en) * 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
ATE427948T1 (de) * 2001-04-24 2009-04-15 Purdue Research Foundation Folat-mimetika und deren folatrezeptorbindende konjugate
EP1501551B1 (en) 2002-05-06 2009-11-18 Endocyte, Inc. Folate-receptor targeted imaging agents
GB0407952D0 (en) * 2004-04-08 2004-05-12 Amersham Plc Fluoridation method
RU2007128036A (ru) 2004-12-23 2009-01-27 Пердью Рисерч Фаундейшн (Us) Способ получения изображения позитронно-эмиссионной томографией
JP5289935B2 (ja) 2005-03-16 2013-09-11 エンドサイト，インコーポレイテッド プテロイン酸およびその結合体の合成と精製
JP2008540338A (ja) * 2005-04-27 2008-11-20 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド 分子画像化プローブのクリックケミストリー合成法
WO2007006041A2 (en) 2005-07-05 2007-01-11 Purdue Research Foundation Imaging and therapeutic method using monocytes
US20080280937A1 (en) 2005-08-19 2008-11-13 Christopher Paul Leamon Ligand Conjugates of Vinca Alkaloids, Analogs, and Derivatives
ES2468240T3 (es) 2005-08-19 2014-06-16 Endocyte, Inc. Conjugados de ligando de múltiples fármacos
US8795633B2 (en) 2005-09-23 2014-08-05 Purdue Research Foundation Multiphoton in vivo flow cytometry method and device
WO2008054404A2 (en) 2005-11-15 2008-05-08 California Institute Of Technology Resonant vibratory device having high quality factor and methods of fabricating same
WO2007139815A2 (en) 2006-05-23 2007-12-06 Purdue Research Foundation Imaging and therapeutic method using progenitor cells
AU2008213702B2 (en) * 2007-02-07 2014-04-24 Purdue Research Foundation Positron emission tomography imaging method
JP5595903B2 (ja) * 2007-04-11 2014-09-24 メルク エ カンパニー １８ｆ標識葉酸
WO2008125617A2 (en) * 2007-04-11 2008-10-23 Merck Eprova Ag 18f-labelled folates
EP2346870B1 (en) * 2008-10-10 2015-08-05 Merck & Cie 18f-labelled folates as pet radiotracers

Also Published As

Publication number Publication date
KR20090130111A (ko) 2009-12-17
CA2670363C (en) 2015-07-21
EP2146944B1 (en) 2014-01-22
WO2008125613A1 (en) 2008-10-23
JP2010523624A (ja) 2010-07-15
CN107573347A (zh) 2018-01-12
EP2146944A1 (en) 2010-01-27
KR20160074683A (ko) 2016-06-28
EA200901347A1 (ru) 2010-04-30
US20150315189A1 (en) 2015-11-05
CA2670363A1 (en) 2008-10-23
IL201248A (en) 2016-02-29
US10377756B2 (en) 2019-08-13
US20100111864A1 (en) 2010-05-06
ES2449774T3 (es) 2014-03-21
KR101781461B1 (ko) 2017-10-23
AU2008237930A1 (en) 2008-10-23
IL201248A0 (en) 2010-05-31
DK2146944T3 (da) 2014-02-03
ZA200903486B (en) 2010-01-27
PT2146944E (pt) 2014-03-11
AU2008237930B2 (en) 2014-03-27
CN101646639A (zh) 2010-02-10

Similar Documents

Publication Publication Date Title
PT2146944E (pt) Processo para a preparação de folatos marcados com 18f
EP2231376A4 (en) Tool for constructing constructs
GB0822826D0 (en) Producton
HK1141013A1 (en) Process for the preparation of certain substituted sulfilimines
ZA200903533B (en) Process for the preparation of rosuvastatin
GB0702854D0 (en) Method for the synthesis of sucrose-6-esters
HK1139129A1 (en) 18f-labelled folates 18f-
ZA200907191B (en) Process for the preparation of gefitiib
ZA201003241B (en) Method for the preparation of morphine compounds
HRP20150775T1 (en) Method for preparing hypoallergens
EP2068904A4 (en) METHODS FOR PREPARING DIAZONAMIDES
HK1207857A1 (en) 18f-labelled folates 18f-
IL206530A0 (en) Process for the preparation of 6-substituted-1-(2h)-isoquinolinones
GB0910201D0 (en) The preparation method of 2-deoxy-l-ribose
IL205082A0 (en) Process for the preparation of tetranorlabdane derivatives
EP2155759A4 (en) METHODS FOR THE PREPARATION OF DIORGANOZINC COMPOUNDS
SI2155679T1 (sl) Metoda za pripravo derivatov 4-formilaminopiperidina
ZA201000802B (en) Process for the preparation of alfuzosin hydrochloride
HU0700818D0 (en) Process for the preparation of polyirocyanates of the diphenylmethone series
EP2173695A4 (en) PROCESS FOR THE PREPARATION OF CIS-4-TERT.-BUTYLCYCLOHEXANOL
GB2464854B (en) Process for the preparation of risperidone
ZA200907537B (en) A method for the preparation of mirtazapine
EP2252149A4 (en) PROCESS FOR PREPARING FENTANYLE
GB0721991D0 (en) Preparation method
EG26107A (en) Way to prepare medicine Alandral